New technologies and directed agents for applications of cancer imaging

Area of Science:

• Oncology
• Radiology
• Biomedical Engineering

Background:

• Molecular imaging enables tissue-specific visualization and quantification of physiological and molecular events in tumors.
• It integrates anatomical, physiological, and metabolic information within a single imaging session.
• The field leverages the targeting of genes and proteins implicated in human diseases.

Purpose of the Study:

• To highlight the advancements and potential of molecular imaging in oncology.
• To discuss the development of novel imaging biomarkers and targeted agents.
• To explore the application of molecular imaging in assessing tumor angiogenesis and treatment response.

Main Methods:

• Utilizing noninvasive imaging modalities such as MRI, PET, and ultrasound.
• Employing novel radioligands and contrast agents for targeted molecular visualization.
• Investigating the combination of different imaging modalities (e.g., MRI and PET) for enhanced flexibility.

Main Results:

• Molecular imaging allows for earlier assessment of treatment response compared to traditional anatomical studies.
• Vascular targeting agents can be evaluated through imaging of tumor angiogenesis.
• Targeted contrast agents facilitate site-directed imaging and potential therapy.

Conclusions:

• Molecular imaging provides a powerful tool for understanding tumor biology and evaluating treatment efficacy.
• Combining imaging modalities can offer synergistic benefits for comprehensive tumor assessment.
• Standardization of molecular imaging techniques is crucial for reliable longitudinal studies of tumor response.